SOURCE: BenchMark Journal

Benchmark Journal

December 17, 2009 07:09 ET

Benchmark Journal Analytical Research on Companies Within Financial, Healthcare and Technology Sectors

TO EDITORS: The Following Is an Investment Opinion Being Issued by Benchmark Journal

LONDON--(Marketwire - December 17, 2009) - Wall Street fell on Tuesday as producer prices rose more than expected, igniting fears of inflationary pressures, and a gauge of manufacturing activity in New York State unexpectedly plunged in December. Indexes down: Dow 0.47 pct; S&P 0.55 pct, NASDAQ 0.50 pct. In light of this Benchmark Journal research team completed in-depth analysis on Health Care REIT Inc. (NYSE: HCN), HCP Inc. (NYSE: HCP), Lincoln National Corp. (NYSE: LNC), King Pharmaceuticals Inc. (NYSE: KG), Genzyme Corp. (NASDAQ: GENZ) and Integrated Device Technology Inc. (NASDAQ: IDTI). To view our research and see what ratings these stocks are getting today, sign up now by clicking on the link below.

Our reports on the above companies contain company, sector and technical analysis and much more. Below are a few teasers:

HCN movement looks good on charts. For last 2 months it is relatively stable at $45 with strong volumes.

Shrinking consumer spending is also adding to the woes of HCP. But at the same time the company is achieving...

LNC received cash injection from the U.S. Treasury earlier this year. Lincoln received $950 million to...

We believe that the combination of all three businesses will continue to contribute to KG's long-term growth strategy.

We point out that despite GENZ's challenges, the firm still produced $363 million in cash from operations during the quarter, and we think...

Although these moves might lead to some promising new product lines for IDTI, the firm will likely struggle in the near term to handle the...

These are just one-liner teasers, Benchmark Journal has compiled a full-blown 6 page report on each of these stocks and they are now available on our members' area, you are simply required to register by clicking the link below:

About Benchmark Journal:

Benchmark Journal brings independent company and sector research together, utilizing top financial advisors and investment tactics to provide you with a clear picture of investment opportunities. Timing and knowledge are essential components of every successful investment, and thus we only release analysis when the timing is ideal for action. has not been compensated by any of the above mentioned companies.